ORKA — Oruka Therapeutics, Inc.
$80.15-1.23%
Last close: · regular session
Last 60 sessions
ORKA closed at $80.15 (-1.23%) on Oct 23, 2026. Active shelf registration (S-3, Aug 2026). Float: 53.1M shares. Latest SEC filing: 8-K on Oct 26, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for ORKA in the TickerWise workspace.
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Employees: 28
- Website: http://www.orukatx.com
Latest SEC filings for ORKA
Latest ORKA news
- Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026 Read article
- Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing Read article
- Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer Read article
- Oruka Stock Is Now Up Nearly 700%. Here's What a $687,000 Insider Sale Could Mean Read article
- Oruka Therapeutics' Head of Finance Sold Over 10,000 Company Shares. What Does That Mean for Investors? Read article
- An Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Million Read article
- Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering Read article
- Oruka Therapeutics Announces Proposed $500 Million Underwritten Public Offering Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.